Providence Ventures, established in 2014 and based in Seattle, Washington, is a venture capital firm that focuses on early to mid-stage investments in the healthcare sector. The firm manages $300 million in venture capital funds on behalf of Providence St. Joseph Health, one of the largest integrated health systems in the United States. Providence Ventures aims to be among the first institutional investors in promising companies, typically deploying between $8 to $15 million over the life of an investment. The firm seeks to align its investments with the innovation priorities of its parent health system, focusing on solutions that improve health outcomes, reduce costs, and enhance patient and caregiver experiences. It specializes in health information technology, digital health, tech-enabled services, and medical devices and diagnostics. While Providence Ventures is open to collaborating with other venture funds as co-investors, such partnerships are not a requirement for its investment strategy. The firm leverages its health system expertise to support portfolio companies in refining their solutions and expanding their market presence.
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.
Livara
Series B in 2024
Livara Health specializes in non-operative, personalized treatment for musculoskeletal conditions, focusing primarily on back and neck pain. The company has developed an orthopedic care management platform that provides a comprehensive, data-driven approach to pain relief. This platform assesses patients' needs and customizes a six-week treatment program, which includes physical therapy coaching and addiction treatment options. Livara aims to help individuals alleviate their musculoskeletal issues through both online and onsite therapy, eliminating the need for surgical interventions.
Praia Health
Series A in 2024
Praia Health is a cutting-edge consumer platform for health systems that transforms the delivery of personalised health solutions on a large scale, allowing digital transformation.
impact.com
Private Equity Round in 2022
Impact is a marketing technology company that specializes in partnership automation, helping brands to enhance their paid marketing and media expenditures. Founded in 2008 in Santa Barbara, California, Impact has expanded to ten offices worldwide and employs over 400 individuals. The company's platform addresses marketers' needs for simplicity and transparency while enabling more effective media measurement, attribution, and optimization. By automating the full lifecycle of partnerships, Impact facilitates the discovery, recruitment, onboarding, engagement, and performance enhancement of various partnership types. Its solutions also focus on preventing ad fraud, thereby fostering informed decision-making. Impact serves a diverse range of global enterprises, including well-known brands, and seeks to drive revenue growth through innovative partnership strategies in the evolving Partnership Economy.
Wildflower Health
Venture Round in 2022
Wildflower Health, Inc. is a health engagement platform based in San Francisco, California, that provides smartphone-based health programs aimed at connecting healthcare payers with families across the United States. Founded in 2012, the company offers a maternity program called Due Date Plus, which addresses engagement challenges by assisting women in early pregnancy and facilitating connections with care managers. Additionally, Wildflower Health provides GROW, a family health program that focuses on mothers and encompasses pediatric and family health. Its platform delivers personalized health milestones based on age and gender, along with resources such as on-device messaging, appointment reminders, health risk assessments, and provider referrals. By utilizing user-centered design and technology, Wildflower Health aims to empower families to make informed healthcare decisions and support their individual health needs over time.
DexCare
Series B in 2022
DexCare is a Seattle-based company founded in 2021 that specializes in providing a platform-as-a-service solution for managing health system capacity and demand across various lines of care. The company's platform aims to transform traditional patient-to-provider relationships into scalable digital experiences, thereby increasing revenue from new patients while reducing acquisition costs. By optimizing access to healthcare services, DexCare helps healthcare institutions generate new patients, enhance satisfaction, achieve cost savings, and ensure that patients receive timely and effective care.
Xealth
Series B in 2021
Xealth Inc. operates a digital health prescribing platform that allows clinicians to integrate, prescribe, and monitor digital health tools directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, the platform facilitates patient engagement by enabling care teams to order appropriate digital health tools and programs, which can be sent to patients via email or patient portals. In addition to managing digital health prescriptions, the platform supports patient education and offers non-clinical services such as ride shares and food delivery. This comprehensive approach allows clinicians to monitor patient activity and engagement, ultimately enhancing the overall effectiveness of digital health initiatives within healthcare systems.
Kno2
Series A in 2021
Kno2 is a developer of a cloud-based health information platform that facilitates the electronic exchange of patient information. The platform is designed to organize, manage, share, and capture unstructured patient data from various sources, including paper documents, faxes, and digital images. By converting this information into the appropriate format, Kno2 ensures that healthcare providers can access it through patient portals. This capability enables providers to make timely and critical medical decisions, improving patient care and streamlining healthcare communication.
Arrive Health
Funding Round in 2021
Arrive Health, founded in 2013 and based in Denver, Colorado, focuses on enhancing access to affordable, quality healthcare by providing precise, patient-specific cost and coverage information. The company develops integrated technologies that streamline workflows within health systems, facilitating conversations about affordability and access. By connecting a network of payers, pharmacy benefit managers, IT vendors, and other tools, Arrive Health alerts providers and care teams to coverage restrictions, lower-cost alternatives, and location-based options. This enables healthcare professionals to make well-informed decisions, ultimately reducing barriers throughout the care continuum.
Protenus
Series D in 2021
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.
TailorMed
Venture Round in 2021
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.
DexCare
Series A in 2021
DexCare is a Seattle-based company founded in 2021 that specializes in providing a platform-as-a-service solution for managing health system capacity and demand across various lines of care. The company's platform aims to transform traditional patient-to-provider relationships into scalable digital experiences, thereby increasing revenue from new patients while reducing acquisition costs. By optimizing access to healthcare services, DexCare helps healthcare institutions generate new patients, enhance satisfaction, achieve cost savings, and ensure that patients receive timely and effective care.
Livara
Series A in 2021
Livara Health specializes in non-operative, personalized treatment for musculoskeletal conditions, focusing primarily on back and neck pain. The company has developed an orthopedic care management platform that provides a comprehensive, data-driven approach to pain relief. This platform assesses patients' needs and customizes a six-week treatment program, which includes physical therapy coaching and addiction treatment options. Livara aims to help individuals alleviate their musculoskeletal issues through both online and onsite therapy, eliminating the need for surgical interventions.
Lyra Health
Series D in 2020
Lyra Health operates a digital health platform that enhances mental health care for employees by connecting them with a curated network of therapists and coaches. Founded in 2015 and based in Burlingame, California, Lyra uses matching technology to pair individuals with suitable providers based on their needs and preferences. The platform offers live video therapy, coaching, and digital self-care tools, ensuring faster access to care and better outcomes compared to traditional plans. Lyra assesses treatment effectiveness using clinical measures like the PHQ-9 and GAD-7 for conditions such as anxiety and depression. This approach results in significantly more people receiving care and achieving improved mental health outcomes.
Lyra Health
Series C in 2020
Lyra Health operates a digital health platform that enhances mental health care for employees by connecting them with a curated network of therapists and coaches. Founded in 2015 and based in Burlingame, California, Lyra uses matching technology to pair individuals with suitable providers based on their needs and preferences. The platform offers live video therapy, coaching, and digital self-care tools, ensuring faster access to care and better outcomes compared to traditional plans. Lyra assesses treatment effectiveness using clinical measures like the PHQ-9 and GAD-7 for conditions such as anxiety and depression. This approach results in significantly more people receiving care and achieving improved mental health outcomes.
Twistle
Venture Round in 2020
Twistle, Inc. operates a patient engagement platform designed to enhance communication between healthcare providers and patients, facilitating faster recovery. Founded in 2011 and headquartered in Seattle, Washington, the platform automates care plan management by monitoring patient care pathways and engaging healthcare teams only when necessary. It offers tools for secure automated messaging, photo and lab sharing, surveys, and integration with electronic health records (EHRs) and smart devices. By enabling medical practitioners to efficiently collect patient data and respond to concerns, Twistle aims to improve patient outcomes, reduce healthcare costs, and streamline clinical workflows. The company was initially incorporated in 2010 and has since focused on delivering a comprehensive solution for personalized patient engagement.
Kyruus
Series D in 2020
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.
Protenus
Series C in 2019
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.
Omada
Series D in 2019
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.
Xealth
Series A in 2019
Xealth Inc. operates a digital health prescribing platform that allows clinicians to integrate, prescribe, and monitor digital health tools directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, the platform facilitates patient engagement by enabling care teams to order appropriate digital health tools and programs, which can be sent to patients via email or patient portals. In addition to managing digital health prescriptions, the platform supports patient education and offers non-clinical services such as ride shares and food delivery. This comprehensive approach allows clinicians to monitor patient activity and engagement, ultimately enhancing the overall effectiveness of digital health initiatives within healthcare systems.
Bolder Surgical
Series C in 2019
Bolder Surgical, founded in 2010 and based in Boulder, Colorado, is dedicated to enhancing surgical practices by designing specialized surgical instruments. The company focuses on creating precisely sized devices that facilitate access to confined and delicate anatomical structures, which is particularly beneficial in pediatric surgery. By catering to the specific needs of surgeons, Bolder Surgical aims to improve procedural approaches and minimize incisions, thereby promoting the safe and effective performance of minimally invasive surgeries for patients ranging from neonates to teenagers.
Lyra Health
Series B in 2018
Lyra Health operates a digital health platform that enhances mental health care for employees by connecting them with a curated network of therapists and coaches. Founded in 2015 and based in Burlingame, California, Lyra uses matching technology to pair individuals with suitable providers based on their needs and preferences. The platform offers live video therapy, coaching, and digital self-care tools, ensuring faster access to care and better outcomes compared to traditional plans. Lyra assesses treatment effectiveness using clinical measures like the PHQ-9 and GAD-7 for conditions such as anxiety and depression. This approach results in significantly more people receiving care and achieving improved mental health outcomes.
Kyruus
Corporate Round in 2018
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.
Collective Medical
Series A in 2017
Collective Medical operates a collaborative care management platform designed to enhance patient outcomes by addressing communication gaps in healthcare. Based in Salt Lake City, the company connects a nationwide network that includes every national health plan, hundreds of hospitals, and tens of thousands of healthcare providers. Its system-agnostic platform leverages real-time data, risk analytics, and shared care guidelines to identify at-risk and complex patients. By facilitating actionable collaboration among care teams, Collective Medical aims to reduce emergency department visits and avoidable readmissions for high-risk patients. The platform improves coordination across diverse care teams, streamlines transitions of care, and supports better decision-making, ultimately ensuring patients receive appropriate care in the right setting.
Intelligent Retinal Imaging Systems
Series B in 2017
Intelligent Retinal Imaging Systems, Inc. specializes in developing cloud-based diagnostic imaging solutions for the examination and detection of diabetic retinopathy. The company offers a comprehensive retinal telemedicine platform that integrates patient identification, examination processes, and billing workflows to enhance efficiency and reimbursement. Its software features a bi-directional EHR interface that diagnoses serious retinal conditions, provides customized care plans, and supports risk adjustment factor (RAF) eligible diagnoses. The platform allows for real-time image reading and classification by human screeners, as well as remote consultations with specialists. Intelligent Retinal Imaging Systems serves a diverse clientele, including primary healthcare providers, physicians, insurers, employers, and care organizations across the United States. Founded in 2011 and headquartered in Pensacola, Florida, the company has established strategic partnerships with institutions like the Florida Institute for Human and Machine Cognition and the Lions Eye Institute to further its mission in preventative eye care.
Bona Film Group
Private Equity Round in 2016
Bona Film Group Limited is a prominent film distributor based in China, specializing in an integrated business model that includes film distribution, production, exhibition, and talent representation. The company distributes films across various regions, including Greater China, Korea, Southeast Asia, the United States, and Europe. In addition to its distribution activities, Bona invests in and produces films across multiple genres. The company also owns and operates twenty movie theaters, enhancing its presence in the cinema market. Furthermore, Bona Film Group manages a diverse roster of talented and popular Chinese artists, positioning itself as a key player in the entertainment industry.
N-of-One
Series B in 2016
N-of-One, Inc. is a molecular decision support company that specializes in the interpretation of molecular test results for cancer care. It provides clinicians with detailed insights into the biological relevance of diseases, clinical evidence, associated therapies, and references. The company interprets next-generation sequencing (NGS) data from solid and hematological tumors, as well as circulating tumor cells and DNA. N-of-One delivers a clinical interpretation report called PrecisionInsights, which covers 15-20 gene NGS panels, summarizing clinical and scientific evidence for each biomarker relevant to specific cancer subtypes and listing potential therapeutic options. Additionally, it offers TRIALMATCH, a solution for matching patients to suitable clinical trials based on their individual profiles. N-of-One serves various stakeholders, including commercial and hospital laboratories and precision medicine programs. Founded in 2007 and based in Lexington, Massachusetts, N-of-One operates as a subsidiary of QIAGEN N.V. since January 2019.
Gauss Surgical
Series B in 2016
Gauss Surgical, Inc. specializes in real-time blood monitoring solutions that enhance clinical decision-making in the healthcare sector. The company has developed a vision-based platform that provides accurate estimations of blood loss, facilitating timely transfusion decisions and improving patient outcomes. Its flagship product, Triton, is utilized in obstetrics to aid in the early detection of postpartum hemorrhage and offers objective metrics for assessing blood loss. Additionally, Gauss Surgical offers Triton OR, designed for operating rooms to measure blood loss from surgical sponges and suction canisters, and Triton L&D, which focuses on vaginal delivery and postpartum care. Founded in 2011, Gauss Surgical operates from its headquarters in Menlo Park, California.
Sqord
Seed Round in 2016
Sqord, Inc. is a company focused on promoting physical activity among children through a socially-connected online platform. Founded in 2011 and based in Durham, North Carolina, Sqord offers a gamification system that combines a low-cost wearable device with an online experience. The Sqord Booster device tracks users' physical activity using a wrist-worn accelerometer and awards points that can be redeemed for various online rewards, such as gift cards and virtual goods. This platform encourages children to engage in physical activities while connecting and competing with peers, including classmates, sports teams, and friends. Sqord primarily serves elementary school students and youth organizations across the United States, addressing the growing concern of declining physical health and promoting healthier lifestyles.
InDemand Interpreting
Venture Round in 2015
InDemand Interpreting is a medical interpretative service company that specializes in bridging the language gap for patients with limited English proficiency as well as deaf and hard-of-hearing individuals. Founded in 2007, the company has pioneered the use of video remote interpreting technology in the healthcare sector. It employs nationally certified medical interpreters who facilitate communication during healthcare encounters through various modalities, including video remote, in-person, and phone services. InDemand Interpreting implements a customized five-point process to enhance the language services programs of healthcare facilities, ensuring that they effectively meet the communication needs of an increasingly diverse patient population.
Sqord
Venture Round in 2015
Sqord, Inc. is a company focused on promoting physical activity among children through a socially-connected online platform. Founded in 2011 and based in Durham, North Carolina, Sqord offers a gamification system that combines a low-cost wearable device with an online experience. The Sqord Booster device tracks users' physical activity using a wrist-worn accelerometer and awards points that can be redeemed for various online rewards, such as gift cards and virtual goods. This platform encourages children to engage in physical activities while connecting and competing with peers, including classmates, sports teams, and friends. Sqord primarily serves elementary school students and youth organizations across the United States, addressing the growing concern of declining physical health and promoting healthier lifestyles.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.